In 2023, the U.S. Will Still Be the #1 Prescription Drug Spender in the World, IQVIA Forecasts
Health Populi
JANUARY 29, 2019
See the dark blue dot in 2023 north of the other dots, representing the median costs for a non-oncology drug with orphan status priced around $300,000. Other key trends to expect leading to 2023 will be: The rise of patient advocacy roles in pharma companies. Thus far, the FDA has been welcoming to these concepts.
96 
Let's personalize your content